Linkage analysis in multiple sclerosis of chromosomal regions syntenic to experimental autoimmune disease loci

被引:24
作者
Xu, C
Dai, YM
Lorentzen, JC
Dahlman, I
Olsson, T
Hillert, J [1 ]
机构
[1] Huddinge Univ Hosp, Karolinska Inst, Dept Neurol, Div Neurol, S-14186 Huddinge, Sweden
[2] Karolinska Hosp, Ctr Mol Med, Rheumatol Unit, S-17176 Stockholm, Sweden
[3] Karolinska Hosp, Ctr Mol Med, Neuroimmunol Unit, S-17176 Stockholm, Sweden
关键词
experimental arthritis; experimental autoimmune encephalomyelitis; genetic susceptibility; genetic linkage; multiple sclerosis; synteny;
D O I
10.1038/sj.ejhg.5200653
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Multiple sclerosis is a demyelinating disorder of the central nervous system with a putative autoimmune aetiology in which several genes are thought to be involved. Four published genomic screens have confirmed that a gene influencing MS resides within or close to the HLA class II region in 6p21. Still, this locus is likely to confer only a part of the genetic susceptibility in MS. Further, all four studies identified a number of other regions with possible linkage. We have investigated eight chromosomal intervals syntenic to loci of importance for experimental autoimmune model diseases in the rat in 74 Swedish MS families. Possible linkage (a non-parametric linkage NPL score of 1.16 by GENEHUNTER computer package) was observed with markers in 12p13.3, a region syntenic to the rat Oia2 locus which is importance for oil induced arthritis (OIA). Four markers in the T cell receptor beta chain gene region in 7q35 showed possible linkage (highest NPL score of 1.16). This locus is syntenic to the rat Cia3 locus (collagen induced arthritis). These two loci at least partially overlap with chromosomal regions showing indicative evidence for linkage in the previous MS genomic screens. Indeed, both Oia2 and Cia3 were recently found to be linked also with experimental autoimmune encephalomyelitis, a commonly used model for MS. Markers in 2p12, 3p25, 10q11.23, 17q21-25, 19q13.1, and 22q12-13 failed to provide evidence for linkage. We conclude that evidence is amounting that 12p13-12 and 7q34-36 may harbour genes with an importance for MS. The synteny with experimental loci may eventually facilitate their identification.
引用
收藏
页码:458 / 463
页数:6
相关论文
共 49 条
[1]  
BAKER D, 1995, J IMMUNOL, V155, P4046
[2]   Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases [J].
Becker, KG ;
Simon, RM ;
Bailey-Wilson, JE ;
Freidlin, B ;
Biddison, WE ;
McFarland, HF ;
Trent, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (17) :9979-9984
[3]   Multiple loci for multiple sclerosis [J].
Bell, JI ;
Lathrop, GM .
NATURE GENETICS, 1996, 13 (04) :377-378
[4]   A role for CD4 in peripheral T cell differentiation [J].
Brown, DR ;
Moskowitz, NH ;
Killeen, N ;
Reiner, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) :101-107
[5]   Genetic epidemiology of multiple sclerosis [J].
Compston, A .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 62 (06) :553-561
[6]   Linkage analysis of multiple sclerosis with candidate region markers in Sardinian and Continental Italian families [J].
D'Alfonso, S ;
Nisticò, L ;
Zavattari, P ;
Marrosu, MG ;
Murru, R ;
Lai, M ;
Massacesi, L ;
Ballerini, C ;
Gestri, D ;
Salvetti, M ;
Ristori, G ;
Bomprezzi, R ;
Trojanò, M ;
Liguori, M ;
Gambi, D ;
Quattrone, A ;
Fruci, D ;
Cucca, F ;
Richiardi, PM ;
Tosi, R .
EUROPEAN JOURNAL OF HUMAN GENETICS, 1999, 7 (03) :377-385
[7]   Linkage analysis of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the rat identifies a locus controlling demyelination on chromosome 18 [J].
Dahlman, I ;
Wallström, E ;
Weissert, R ;
Storch, M ;
Kornek, B ;
Jacobsson, L ;
Linington, C ;
Luthman, H ;
Lassmann, H ;
Olsson, T .
HUMAN MOLECULAR GENETICS, 1999, 8 (12) :2183-2190
[8]  
Dahlman I, 1998, EUR J IMMUNOL, V28, P2188, DOI 10.1002/(SICI)1521-4141(199807)28:07<2188::AID-IMMU2188>3.0.CO
[9]  
2-B
[10]  
Dahlman I, 1999, J IMMUNOL, V162, P2581